Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)
101.21
-2.61 (-2.51%)
At close: Apr 24, 2026
SHA:688198 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 663.57 | 620.15 | 500.26 | 369.91 | 295.07 | 251.8 |
Other Revenue | - | - | 1.61 | 0.73 | 0.1 | 0.02 |
| 663.57 | 620.15 | 501.88 | 370.64 | 295.17 | 251.82 | |
Revenue Growth (YoY) | 26.21% | 23.57% | 35.41% | 25.57% | 17.21% | 38.42% |
Cost of Revenue | 69.78 | 67.09 | 58.52 | 37.64 | 31.36 | 29.61 |
Gross Profit | 593.79 | 553.06 | 443.35 | 333 | 263.81 | 222.21 |
Selling, General & Admin | 218.96 | 202.29 | 154.92 | 131.97 | 123.77 | 131.16 |
Research & Development | 150.46 | 155.33 | 151.44 | 98.81 | 55.15 | 58.9 |
Other Operating Expenses | 3.02 | -10.36 | 3.46 | 1.25 | 1.62 | 1.17 |
Operating Expenses | 372.44 | 347.26 | 312.22 | 233.5 | 181.64 | 192.04 |
Operating Income | 221.35 | 205.8 | 131.14 | 99.5 | 82.17 | 30.17 |
Interest Expense | - | - | -0.46 | -0.41 | -0.08 | -0.12 |
Interest & Investment Income | 7.27 | 7.85 | 17.32 | 17.66 | 22.53 | 16.49 |
Currency Exchange Gain (Loss) | - | - | 0.05 | -0.26 | 0 | - |
Other Non Operating Income (Expenses) | -8.37 | -8.35 | -0.16 | -0.06 | -0.68 | -0.05 |
EBT Excluding Unusual Items | 220.25 | 205.3 | 147.89 | 116.43 | 103.94 | 46.5 |
Gain (Loss) on Sale of Investments | 0.72 | 0.83 | 0.74 | 1 | 0.89 | 0.97 |
Gain (Loss) on Sale of Assets | 0.01 | 0 | -0.05 | 0.05 | -0.01 | -0.02 |
Other Unusual Items | - | - | 2.2 | 2.54 | 1.32 | 2.31 |
Pretax Income | 220.98 | 206.13 | 150.79 | 120.02 | 106.14 | 49.76 |
Income Tax Expense | 28.1 | 26.45 | 18.64 | 10.61 | 11.74 | -1.51 |
Earnings From Continuing Operations | 192.88 | 179.68 | 132.14 | 109.41 | 94.39 | 51.26 |
Minority Interest in Earnings | 9.56 | 13.89 | 14.19 | 5.8 | 0.73 | -0.06 |
Net Income | 202.44 | 193.57 | 146.33 | 115.21 | 95.13 | 51.2 |
Net Income to Common | 202.44 | 193.57 | 146.33 | 115.21 | 95.13 | 51.2 |
Net Income Growth | 18.72% | 32.28% | 27.02% | 21.11% | 85.80% | -9.42% |
Shares Outstanding (Basic) | 138 | 137 | 137 | 136 | 136 | 135 |
Shares Outstanding (Diluted) | 138 | 137 | 137 | 137 | 136 | 135 |
Shares Change (YoY) | 1.44% | 0.39% | -0.29% | 0.92% | 0.86% | 0.44% |
EPS (Basic) | 1.47 | 1.41 | 1.07 | 0.85 | 0.70 | 0.38 |
EPS (Diluted) | 1.47 | 1.41 | 1.07 | 0.84 | 0.70 | 0.38 |
EPS Growth | 17.04% | 31.78% | 27.38% | 20.00% | 84.21% | -9.82% |
Free Cash Flow | 55.26 | 61.6 | -27.02 | 12.53 | 24.01 | 4.27 |
Free Cash Flow Per Share | 0.40 | 0.45 | -0.20 | 0.09 | 0.18 | 0.03 |
Dividend Per Share | - | - | 0.800 | 0.800 | 0.500 | 0.357 |
Dividend Growth | - | - | - | 60.00% | 40.02% | 149.90% |
Gross Margin | 89.48% | 89.18% | 88.34% | 89.84% | 89.38% | 88.24% |
Operating Margin | 33.36% | 33.19% | 26.13% | 26.85% | 27.84% | 11.98% |
Profit Margin | 30.51% | 31.21% | 29.16% | 31.08% | 32.23% | 20.33% |
Free Cash Flow Margin | 8.33% | 9.93% | -5.38% | 3.38% | 8.14% | 1.70% |
EBITDA | 264.19 | 243.94 | 150.45 | 110.7 | 87.78 | 36.19 |
EBITDA Margin | 39.81% | 39.34% | 29.98% | 29.87% | 29.74% | 14.37% |
D&A For EBITDA | 42.84 | 38.14 | 19.31 | 11.19 | 5.61 | 6.02 |
EBIT | 221.35 | 205.8 | 131.14 | 99.5 | 82.17 | 30.17 |
EBIT Margin | 33.36% | 33.19% | 26.13% | 26.85% | 27.84% | 11.98% |
Effective Tax Rate | 12.72% | 12.83% | 12.36% | 8.84% | 11.06% | - |
Revenue as Reported | - | - | 501.88 | 370.64 | 295.17 | 251.82 |
Advertising Expenses | - | - | 2.01 | 0.37 | 1.12 | 1.22 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.